Shanda Asset Management Holdings’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
VCM
VPM
Shanda Asset Management Holdings's MRNA Position: Q1 2026 in Review
Shanda Asset Management Holdings sold out of Moderna (MRNA) in Q1 2026, closing a stake of 300,000 shares — an estimated $14M sold.
Shanda Asset Management Holdings first reported a position in MRNA in Q2 2020 and held it in 3 quarters. The position peaked at $28.4M in Q1 2025. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- Shanda Asset Management Holdings reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
- Shanda Asset Management Holdings sold 300,000 Moderna shares in Q1 2026, an estimated $14M.
- Shanda Asset Management Holdings first reported a position in Moderna in Q2 2020 and held it in 3 quarters.
- Shanda Asset Management Holdings's Moderna position peaked at $28.4M in Q1 2025.
- 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on Shanda Asset Management Holdings's 13F filing for Q1 2026, filed 15 May 2026.